
Voglitus 0.2mg Tablet
Marketer
Tusker Pharma Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Voglitus 0.2mg Tablet
Diabetac 0.2mg tablets are prescribed for managing type 2 diabetes. This medication helps regulate post-prandial hyperglycemia (high blood sugar after meals). It's indicated when dietary modifications and other similar treatments prove insufficient to control elevated blood glucose. Diabetac 0.2mg tablets should be administered immediately before meals. Dosage and frequency are determined by your physician to achieve optimal glycemic control. Discontinue use only after consulting your doctor; abrupt cessation can elevate blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabetac 0.2mg tablets alone do not typically cause hypoglycemia, concomitant use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. Glucose should be administered to counteract hypoglycemic episodes; sucrose or other common sugars may be ineffective. Inform your physician of any pre-existing kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all other medications you are currently taking to ensure treatment safety. Limit alcohol consumption while using this medication to minimize the risk of hypoglycemia.
Uses of Voglitus 0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Voglitus 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Voglitus tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Voglitus 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglitus 0.2mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 0.2mg Voglitus tablet whole; avoid chewing, crushing, or breaking it. Consumption should occur on an empty stomach.
How Voglitus 0.2mg Tablet works:
Each 0.2mg Voglitus tablet functions as an anti-diabetic medication. Its mechanism involves suppressing intestinal enzymes that digest complex carbohydrates into simpler sugars like glucose, thereby moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglitus 0.2mg tablets and alcohol is hazardous.
PregnancySAFE IF PRESCRIBED
Use of Voglitus 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglitus 0.2mg tablets without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Voglitus 0.2mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglitus 0.2mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglitus 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglitus 0.2mg Tablet :
Omit any missed Voglitus 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglitus 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
